Efficacy of Additional Osteotomies to Correct Hallux Valgus
NCT ID: NCT04145882
Last Updated: 2024-02-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
515 participants
INTERVENTIONAL
2019-09-11
2026-09-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Insufficient surgical correction is a risk factor of recurrence (HVA\>20° after surgery). According to Okuda et al in a 67 patients group treated by proximal osteotomies correction, postoperative risk factors of recurrence at 33 month of follow-up are : HVA\>40° before the surgery and HVA\>15° with an IMA\>10° 10 weeks (3-24) after the surgery.
Currently, one of the most common used procedure is a translated (laterally) distal chevron associated with a release of the metatarso-sesamoid suspensory ligament and a Akin procedure on P1. Nevertheless this procedure does not correct deformation in all plans. HVA and IMA are corrected but DMAA and M1 pronation angle are not.
Surgeons can add three different osteotomies in this type of chevron. In the dorsal saw cut a varisation wedge osteotomy is possible , in the plantar saw cut a supination wedge osteotomy is possible, and both are possible. No studies have tried to assess these three possibilities.
The investigators hypothesize that the addition of a varisation and/or a supination wedge osteotomies in a distal chevron decrease risk factors of recurrence at six months of follow-up
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Proximal Metatarsal Osteotomy in Correction of Hallux Valgus
NCT06584487
Functional and Radiographic Outcomes of Hallux Valgus Correction by Mini-invasive Surgery With Reverdin-Isham Percutaneous Osteotomy
NCT02886221
Chevron Osteotomy Versus SCARF Osteotomy in the Treatment of Hallux Valgus
NCT00455676
Transarticular Lateral Release Versus Percutaneous Lateral Release for Hallux Valgus
NCT04614675
Human Bone Graft for Hallux Valgus Correction According to the Austin Procedure
NCT03884907
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No additional osteotomy
additional osteotomies
varisation osteotomy, supination osteotomy or both
varisation osteotomy addition
additional osteotomies
varisation osteotomy, supination osteotomy or both
supination osteotomy addition
additional osteotomies
varisation osteotomy, supination osteotomy or both
both (varisation + supination) osteotomies addition.
additional osteotomies
varisation osteotomy, supination osteotomy or both
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
additional osteotomies
varisation osteotomy, supination osteotomy or both
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent
Exclusion Criteria
* Associated surgery on midfoot, hindfoot or ankle.
* Neurologic diseases (Charcot Marie Tooth disease, poliomyelitis, compartment syndrome sequelae)
* Clinical or X-ray degenerative signs (Hallux rigidus) or irreducible deformations (MTP1 arthrodesis indications).
* Patient who declined the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Elsan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Lille sud
Lesquin, , France
Clinique du Parc Lyon
Lyon, , France
Clinique Mégival
Saint-Aubin-sur-Scie, , France
Clinique de l'Union
Saint-Jean, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CPL-2019-HV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.